Neuroprotection in hypertensive patients: Minimization of poor prognosis
The paper discusses approaches to optimizing pharmacotherapy in patients with hypertension associated with cerebrovascular diseases. Possible indications for neuroprotectors and a pathogenetic rationale for their mechanism of action in patients with prior cerebral stroke are detailed.
Main Author: | V N Shishkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2014-08-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31609 |
Similar Items
-
Quest for Quality in Translational Stroke Research—A New Dawn for Neuroprotection?
by: Matteo Haupt, et al.
Published: (2022-05-01) -
New possibilities of neuroprotection in ischemic stroke
by: D. V. Sergeyev, et al.
Published: (2011-12-01) -
The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review
by: Zili Feng, et al.
Published: (2019-12-01) -
Neuroprotective effect of endophytic fungal antioxidant polyphenols on cerebral ischemic stroke-induced Albino rats; memory impairments, brain damage, and upregulation of metabolic proteins
by: Palanisamy Manikandan, et al.
Published: (2023-01-01) -
Neuroprotective Effect of Compound Anisodine in a Mouse Model with Chronic Ocular Hypertension
by: Wen-Dong Liu, et al.
Published: (2015-01-01)